CREB1 and Rubinstein-Taybi syndrome: Since the disturbance of CREB function is known to develop and progress Huntington’s disease, Rubinstein-Taybi syndrome, and major depressive disorder [62,63,64], we will also try to expand the use of CLMIX or its individual LO for treatment of these diseases.